COMMUNIQUÉS West-GlobeNewswire

Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
17/11/2025
MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion of the [...]
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
17/11/2025
NEEDHAM, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]
Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth’s Novel AI-Powered Breast Cancer Detection Workflow
17/11/2025
Largest real-world analysis of AI-driven breast cancer screening in U.S. history 1 demonstrates increased cancer detection rate with consistent benefits across patient populations LOS ANGELES and SOMERVILLE, Mass., Nov [...]
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/11/2025
MALVERN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference
17/11/2025
WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will [...]
Fennec Pharmaceuticals Announces Closing of Offering of Common Shares
17/11/2025
RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced the closing of its [...]
Crescent Biopharma Announces Grants of Inducement Awards
17/11/2025
WALTHAM, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer [...]
Eviden-built JUPITER Supercomputer Hits Exascale Milestone According to the TOP500, a First in Europe
17/11/2025
Paris, France – November 17, 2025 – Eviden , the Atos Group product brand leading in advanced computing, announces today the rankings of its 58 Eviden-built systems 1 in the TOP500 and Green500 , official listings of [...]
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
17/11/2025
WAYNE, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory [...]
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Komzifti™ (ziftomenib)
17/11/2025
LOUISVILLE, Ky. , Nov. 17, 2025 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Kura Oncology for Komzifti ™ (ziftomenib), indicated for [...]
Communiqué de presse : Sanofi réaffirme son engagement à innover depuis la France pour le monde
17/11/2025
Choose France – Édition France 2025 Sanofi réaffirme son engagement à innover depuis la France pour le monde Paris, 17 novembre 2025. À l'occasion du premier sommet Choose France dédié aux entreprises françaises, Sanofi [...]
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference
17/11/2025
PRINCETON, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable [...]
Cerevance to Participate in the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit
17/11/2025
BOSTON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, today [...]
Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases
17/11/2025
Early patient data from Phase 2b clinical trial showed significant and selective tumor uptake in brain metastases compared to MRI Phase 2b clinical trial expected to complete enrollment and have topline data in 1H26 [...]
Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the 26th Annual Meeting of the Society of Urologic Oncology
17/11/2025
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that [...]
ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals
17/11/2025
UNIONDALE, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) reminds shareholders of record as of October 20, 2025, of the Company's upcoming Special Meeting of Stockholders, which will be held on [...]
Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from Post Hoc Analysis of Pancreatic Cancer PoC Study
17/11/2025
EORTC QLQ-C30 subgroup results confirm broad and durable quality-of-life improvements across disease stages and metastasis status, complementing previously reported pain reduction and opioid-free outcomes Late-stage [...]
PetVivo Holdings Announces Digital Landia’s Publication of Technical Whitepaper Validating AgenticPet AI Framework Under Exclusive 10-Year Licensing Agreement
17/11/2025
Comprehensive Documentation Confirms Production-Ready Architecture for PetVivo’s Veterinary Platform Launching Q1 2026 MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), [...]
Porosome Therapeutics Publishes Preclinical Findings Demonstrating Restoration of Neuronal Secretion and Reversal of Alzheimer’s Disease Pathology Following Porosome Reconstitution Therapy
17/11/2025
Human brain organoid studies demonstrated significant improvement in neuronal growth, morphology, and function These findings highlight the potential of the porosome – a central node in cellular communication – as a [...]

Pages